Camille Hertzka

Camille Hertzka possesses extensive experience in the oncology sector, currently serving as the Vice President, Global Franchise Head for Oncology R&D at AstraZeneca. Previously, Camille held multiple leadership roles at AstraZeneca, including Vice President, Head of Oncology US Medical and Vice President, Global Product Leader for Lynparza. Prior to this, Camille worked at Bristol-Myers Squibb as the Regional Medical Lead for Europe in Immuno-Oncology and as the Associate European Medical Lead for Immuno-Oncology melanoma. Camille's career also includes a position as Medical Manager for Oncology at Roche, focusing on medications such as Tarceva and Avastin.